Abstract
Venous thromboembolism comprising deep venous thrombosis and pulmonary embolus is
common. Patients with venous thromboembolism may present to a variety of health care
providers, and while a significant proportion of patients begin treatment in the hospital,
ambulatory management of both deep venous thrombosis and pulmonary embolus is feasible
and becoming more common. Initial anticoagulant management, investigation of venous
thromboembolism etiology, and decisions about extended anticoagulation require coordinated
care by physicians from multiple specialties. Comprehensive management of venous thromboembolism
requires coordinated care from the time of presentation in order to expedite diagnosis,
initiate timely anticoagulant treatment, determine the need for extended anticoagulation
based on risk of bleeding and recurrent thrombosis, and advise on thromboprophylaxis
during future high-risk periods for venous thromboembolism. In this review we use
case scenarios to provide an operational framework, based on current evidence-based
recommendations, for informed decision-making about a number of clinical practice
issues that are frequently encountered in the management of venous thromboembolism
patients.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The epidemiology of venous thromboembolism.J Thromb Thrombolysis. 2016; 41: 3-14
- Diagnosis of venous thromboembolism: 20 years of progress.Ann Intern Med. 2018; 168: 131-140
- Diagnosis of pulmonary embolism with D-dimer adjusted to clinical probability.N Engl J Med. 2019; 381: 2125-2134
- Ambulatory versus in-hospital treatment of proximal lower-limb deep vein thrombosis in adults: a retrospective cohort study.Clin Appl Thromb Hemost. 2017; 23: 859-864
- Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis.Thromb Res. 2013; 132: 515-519
- Venous thromboembolism: advances in diagnosis and treatment.JAMA. 2018; 320: 1583-1594
- Long-term treatment of venous thromboembolism.Blood. 2020; 135: 317-325
- Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer.Ann Intern Med. 2001; 135: 98-107
- Prediction of pulmonary embolism in the emergency department: the revised Geneva Score.Ann Intern Med. 2006; 144: 165-171
- Efficacy and safety of anticoagulant prophylaxis to prevent venous hromboembolism in acutely ill medical inpatients: a meta-analysis.J Intern Med. 2008; 263: 52-60
- Validation of risk assessment models predicting venous thromboembolism in acutely ill medical inpatients: a cohort study.J Thromb Haemos. 2020; 18: 1398-1407
- DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines.Blood Adv. 2020; 4: 1512-1517
- Contemporary meta-analysis of extended direct-acting oral anticoagulant thromboprophylaxis to prevent venous thromboembolism.Am J Med. 2020;; 133: 1074-1081
- Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.Blood. 2014; 124: 1968-1975
- Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.Blood. 2018; 132: 1365-1371
- EULAR recommendations for the management of antiphospholipid syndrome in adults.Ann Rheum Dis. 2019; 78: 1296-1304
- Predicting adverse outcome in patients with acute pulmonary embolism: a risk score.Thromb Haemost. 2000; 84: 548-552
- Simplification of the Pulmonary Embolism Severity Index for prognostication in patients with acute symptomatic pulmonary embolism.Arch Intern Med. 2010; 170: 1383-1389
- Mounting evidence for safe home treatment of selected patients with acute pulmonary embolism.Ann Intern Med. 2018; 169: 881-882
- Thrombophilia testing and venous thrombosis.N Engl J Med. 2017; 377: 2298
- Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH.J Thromb Haemost. 2016; 14: 1480-1483
- Screening for occult cancer in unprovoked venous thromboembolism.N Engl J Med. 2015; 373: 697-704
- Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.Cochrane Database Syst Rev. 2018; 11CD010837
- Thrombophilia evaluation in pulmonary embolism.Curr Opin Cardiol. 2019; 34: 603-609
- Guidance for the evaluation and treatment of hereditary and acquired thrombophilia.J Thromb Thrombolysis. 2016; 41: 154-164
- Venous thromboembolism and women's health.Br J Haematol. 2018; 183: 346-363
- Comparative incidence of pregnancy outcomes in thrombophilia-positive women from the NOH-APS observational study.Blood. 2014; 123: 414-421
- Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study.Lancet. 2003; 362: 523-526
- Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to D-dimer results: a cohort study.J Thromb Haemost. 2019; 17: 1144-1152
- Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy.CMAJ. 2008; 179: 417-426
- Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).J Thromb Haemost. 2012; 10: 1019-1025
- Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.Circulation. 2010; 121: 1630-1636
- Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study.BMJ. 2017; 356: j1065
- D‐dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study.Blood. 2014; 124: 196-203
- Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.N Engl J Med. 2013; 368: 709-718
- Apixaban for extended treatment of venous thromboembolism.N Engl J Med. 2013; 368: 699-708
- Rivaroxaban or aspirin for extended treatment of venous thromboembolism.N Engl J Med. 2017; 376: 1211-1222
- Extended anticoagulation for VTE: a systematic review and meta-analysis.Chest. 2019; 155: 1199-1216
- Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report.Chest. 2016; 149: 315-352
- International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer.Lancet Oncol. 2016; 17: e452-e466
- Edoxaban for the treatment of cancer-associated venous thromboembolism.N Engl J Med. 2018; 378: 615-624
- Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D).J Clin Oncol. 2018; 36: 2017-2023
- Apixaban and dalteparin in active malignancy-associated venous thromboembolism: the ADAM-VTE trial.J Thromb Haemost. 2020; 18: 411-421
- Apixaban for the treatment of venous thromboembolism associated with cancer.N Engl J Med. 2020; 382: 1599-1607
- Impact of adding aspirin to direct oral anticoagulant therapy without an apparent indication.Blood. 2019; (Supplement. Abstract 787)
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).Eur Heart J. 2020; 41: 543-603
- Risk of recurrent venous thromboembolism according to baseline risk factor profiles.Blood Adv. 2018; 2: 788-796
- Use of intermittent pneumatic compression and not graduated compression stockings is associated with lower incident VTE in critically ill patients: a multiple propensity scores adjusted analysis.Chest. 2013; 144: 152-159
- Venous thrombosis risk after arthroscopy of the knee: derivation and validation of the L-TRiP(ascopy) score.Thromb Haemost. 2018; 118: 1823-1831
- Thromboprophylaxis after knee arthroscopy.N Engl J Med. 2017; 376: 580-583
Article info
Publication history
Published online: October 24, 2020
Footnotes
Funding: None.
Conflict of Interest: None.
Authorship: Both authors prepared the manuscript.
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
